Aileron Therapeutics, Inc. (ALRN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aileron Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.05x | -0.66x | -0.89x | -0.40x | -1.94x | -1.66x |
| P/B Ratio | 3.08x | 0.76x | 2.04x | 0.58x | 1.14x | 2.98x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.70x | 2.38x | 4.17x | 6.46x | 10.69x | 4.12x |
| Quick Ratio | 0.70x | 2.38x | 4.17x | 6.46x | 10.69x | 4.12x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.03x |
YoY = year-over-year change. Source: FMP..